| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT05777031 Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-05 | NCT05777031 Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP… |
Enrollment reduced: 22 -> 12 participants |
| 2026-06-05 | NCT06751290 The Use of Cyproheptadine in Pediatric Feeding Disorders |
Trial completed |
| 2026-06-05 | NCT06751290 The Use of Cyproheptadine in Pediatric Feeding Disorders |
Enrollment reduced: 50 -> 18 participants |
| 2026-06-04 | NCT06412120 Study Evaluating Safety, Tolerability, and Metabolism of Niraparib |
date change Primary completion pushed: 2029-06-01 -> 2029-08-01 |
| 2026-06-04 | NCT06412120 Study Evaluating Safety, Tolerability, and Metabolism of Niraparib |
date change Completion pushed: 2031-06-01 -> 2031-08-01 |
| 2026-06-02 | NCT07392580 Intralesional Chemotherapy (IC): Cisplatin + Epinephrine |
Recruitment opened |
| 2026-06-02 | NCT07392580 Intralesional Chemotherapy (IC): Cisplatin + Epinephrine |
date change Primary completion pushed: 2031-04-01 -> 2031-09-01 |
| 2026-06-02 | NCT07392580 Intralesional Chemotherapy (IC): Cisplatin + Epinephrine |
date change Completion pushed: 2031-04-01 -> 2031-09-01 |
| 2026-05-29 | NCT06952790 Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study |
date change Primary completion pushed: 2026-06-01 -> 2026-09-01 |
| 2026-05-29 | NCT06952790 Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study |
date change Completion pushed: 2026-06-01 -> 2026-10-01 |
| 2026-05-29 | NCT06588608 Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI) |
Trial completed |
| 2026-05-29 | NCT06588608 Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI) |
date change Primary completion moved earlier: 2026-12-31 -> 2026-04-24 |
| 2026-05-29 | NCT06588608 Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI) |
date change Completion moved earlier: 2026-12-31 -> 2026-04-24 |
| 2026-05-23 | NCT07365813 Testing Alcohol Cancer Risk Messages |
overall status: "Not Yet Recruiting" → "Enrolling By Invitation" |
| 2026-05-23 | NCT05935644 ORCHID: An Online Intervention for Persons With HIV (Miami) |
overall status: "Enrolling By Invitation" → "Suspended" |
| 2026-05-23 | NCT05935644 ORCHID: An Online Intervention for Persons With HIV (Miami) |
critical why stopped: null → "Lapse in funding" |
| 2026-05-21 | NCT05208697 Tele-Harm Reduction |
Trial completed |
| 2026-05-20 | NCT07572110 Project Independence |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07636161 PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon) | Phase 4 | Not Yet Recruiting |
| 2026-06-03 | NCT07622901 Fasting InTervention for Endometrial Cancer | Recruiting | |
| 2026-06-02 | NCT07620639 Consciousness Studies and Cardiovascular Health | Not Yet Recruiting | |
| 2026-05-18 | NCT07594015 Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07401134 | Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol… | Perineal Injury | Recruiting |
| NCT07217678 | Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive… | Glaucoma | Recruiting |
| NCT06807866 | Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT | THA | Recruiting |
| NCT06774079 | Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel… | Crohn Disease | Recruiting |
| NCT06902285 | Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty | Sleep | Recruiting |
| NCT07426458 | Ventilation and Perfusion in Asthmatics | Asthma | Recruiting |
| NCT06412120 | Study Evaluating Safety, Tolerability, and Metabolism of Niraparib | Ovarian Cancer | Recruiting |
| NCT07216586 | Zynrelef Versus Adductor Canal Block | Knee Osteoarthritis | Not Yet Recruiting |
| NCT07224035 | Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1 | H Pylori Infection | Active, Not Recruiting |
| NCT07224048 | Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 | H. Pylori Infection | Active, Not Recruiting |
| NCT07278362 | Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under… | Prostate Cancer | Not Yet Recruiting |
| NCT04304768 | Opioid, HIV and Immune System | Immune Defect | Active, Not Recruiting |
| NCT07494136 | Dose Dependent Steroid Injections | Lumbar Radiculopathy | Not Yet Recruiting |
| NCT07501065 | Prophylactic Antibiotics for Outpatient Urethral Bulking | Urinary Tract Infections | Not Yet Recruiting |
| NCT03856632 | Liraglutide Effect in Atrial Fibrillation | Atrial Fibrillation | Active, Not Recruiting |
| NCT04487041 | Tfh Dysfunction in HIV and Aging | Human Influenza | Active, Not Recruiting |
| NCT05777031 | Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP… | Peyronie Disease | Active, Not Recruiting |
| NCT07636161 | PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon) | Type 2 Diabetes | Not Yet Recruiting |
| Phase 3 | |||
| NCT05903859 | Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI) | Infertility, Male | Recruiting |
| NCT07472413 | Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project | Multiple Sclerosis | Not Yet Recruiting |
| Phase 2 | |||
| NCT06111313 | The University of Miami Adapt (UAdapt) Trial | Prostate Cancer | Recruiting |
| NCT05530421 | Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory… | Relapsed and Refractory Multiple Myeloma | Recruiting |
| NCT06627244 | Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma | Metastatic Uveal Melanoma | Recruiting |
| NCT06919939 | Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large… | Large B-cell Lymphoma | Recruiting |
| NCT04295486 | Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint… | Venous Thromboembolism | Recruiting |